Levemir is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Detemir.
| Product ID | 0169-3687_18faddbd-0bc0-48d1-a16f-f4939de3d0a3 |
| NDC | 0169-3687 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levemir |
| Generic Name | Insulin Detemir |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2006-03-27 |
| Marketing Category | BLA / NDA |
| Application Number | BLA021536 |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN DETEMIR |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2006-03-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA021536 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2006-03-27 |
| Ingredient | Strength |
|---|---|
| INSULIN DETEMIR | 100 [iU]/mL |
| SPL SET ID: | d38d65c1-25bf-401d-9c7e-a2c3222da8af |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-3687 | Levemir | insulin detemir |
| 0169-6432 | Levemir | insulin detemir |
| 0169-6438 | Levemir | insulin detemir |
| 50090-1276 | Levemir | insulin detemir |
| 50090-1475 | Levemir | insulin detemir |
| 50090-4501 | Levemir | insulin detemir |
| 68258-8977 | Levemir | insulin detemir |
| 70518-1387 | Levemir | insulin detemir |
| 70518-1462 | Levemir | insulin detemir |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LEVEMIR 76468735 2808088 Live/Registered |
Novo Nordisk A/S 2002-11-07 |